The global market for Antiemetic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer.

The adoption of inorganic growth strategies including M&As, partnerships, and regional acquisition, result in improved market penetration of the vendors. Technological advancements result in improvement and expansion of the product portfolio and R&D advancements. Collaborations or acquisitions of the regional players or the complete acquisition of products will contribute to the growth of the antiemetic drug market as it expands the geographical presence of the acquiring vendor.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiemetic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiemetic Drugs.

The Antiemetic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiemetic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiemetic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiemetic Drugs Market Report

Report Metric	Details
Report Name	Antiemetic Drugs Market
Segment by Type	Dopamine Antagonist 5-HT-3 Receptor Antagonist NK1 Receptor Antagonist Cannabinoid Receptor Antagonist
Segment by Application	Chemotherapy Gastroenteritis Surgery
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai, Eli Lilly, Glenmark, Helsinn Healthcare, Heron Therapeutics, IPCA Laboratories, Lupin, Merck, Novartis, RedHill, Sun Pharmaceutical Industries, Takeda Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiemetic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiemetic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antiemetic Drugs Market report?

Ans: The main players in the Antiemetic Drugs Market are GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott, Bristol-Myers Squibb, Cipla, Eisai, Eli Lilly, Glenmark, Helsinn Healthcare, Heron Therapeutics, IPCA Laboratories, Lupin, Merck, Novartis, RedHill, Sun Pharmaceutical Industries, Takeda Pharmaceutical

What are the Application segmentation covered in the Antiemetic Drugs Market report?

Ans: The Applications covered in the Antiemetic Drugs Market report are Chemotherapy, Gastroenteritis, Surgery

What are the Type segmentation covered in the Antiemetic Drugs Market report?

Ans: The Types covered in the Antiemetic Drugs Market report are Dopamine Antagonist, 5-HT-3 Receptor Antagonist, NK1 Receptor Antagonist, Cannabinoid Receptor Antagonist

1 Antiemetic Drugs Market Overview

1.1 Product Definition

1.2 Antiemetic Drugs by Type

1.2.1 Global Antiemetic Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Dopamine Antagonist

1.2.3 5-HT-3 Receptor Antagonist

1.2.4 NK1 Receptor Antagonist

1.2.5 Cannabinoid Receptor Antagonist

1.3 Antiemetic Drugs by Application

1.3.1 Global Antiemetic Drugs Market Value by Application (2024 VS 2031)

1.3.2 Chemotherapy

1.3.3 Gastroenteritis

1.3.4 Surgery

1.4 Global Antiemetic Drugs Market Size Estimates and Forecasts

1.4.1 Global Antiemetic Drugs Revenue 2020-2031

1.4.2 Global Antiemetic Drugs Sales 2020-2031

1.4.3 Global Antiemetic Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Antiemetic Drugs Market Competition by Manufacturers

2.1 Global Antiemetic Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Antiemetic Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Antiemetic Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Antiemetic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antiemetic Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antiemetic Drugs, Product Type & Application

2.7 Global Key Manufacturers of Antiemetic Drugs, Date of Enter into This Industry

2.8 Global Antiemetic Drugs Market Competitive Situation and Trends

2.8.1 Global Antiemetic Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antiemetic Drugs Players Market Share by Revenue

2.8.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antiemetic Drugs Market Scenario by Region

3.1 Global Antiemetic Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Antiemetic Drugs Sales by Region: 2020-2031

3.2.1 Global Antiemetic Drugs Sales by Region: 2020-2025

3.2.2 Global Antiemetic Drugs Sales by Region: 2026-2031

3.3 Global Antiemetic Drugs Revenue by Region: 2020-2031

3.3.1 Global Antiemetic Drugs Revenue by Region: 2020-2025

3.3.2 Global Antiemetic Drugs Revenue by Region: 2026-2031

3.4 North America Antiemetic Drugs Market Facts & Figures by Country

3.4.1 North America Antiemetic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Antiemetic Drugs Sales by Country (2020-2031)

3.4.3 North America Antiemetic Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Antiemetic Drugs Market Facts & Figures by Country

3.5.1 Europe Antiemetic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Antiemetic Drugs Sales by Country (2020-2031)

3.5.3 Europe Antiemetic Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antiemetic Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Antiemetic Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Antiemetic Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Antiemetic Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Antiemetic Drugs Market Facts & Figures by Country

3.7.1 Latin America Antiemetic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Antiemetic Drugs Sales by Country (2020-2031)

3.7.3 Latin America Antiemetic Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Antiemetic Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Antiemetic Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Antiemetic Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Antiemetic Drugs Sales by Type (2020-2031)

4.1.1 Global Antiemetic Drugs Sales by Type (2020-2025)

4.1.2 Global Antiemetic Drugs Sales by Type (2026-2031)

4.1.3 Global Antiemetic Drugs Sales Market Share by Type (2020-2031)

4.2 Global Antiemetic Drugs Revenue by Type (2020-2031)

4.2.1 Global Antiemetic Drugs Revenue by Type (2020-2025)

4.2.2 Global Antiemetic Drugs Revenue by Type (2026-2031)

4.2.3 Global Antiemetic Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Antiemetic Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Antiemetic Drugs Sales by Application (2020-2031)

5.1.1 Global Antiemetic Drugs Sales by Application (2020-2025)

5.1.2 Global Antiemetic Drugs Sales by Application (2026-2031)

5.1.3 Global Antiemetic Drugs Sales Market Share by Application (2020-2031)

5.2 Global Antiemetic Drugs Revenue by Application (2020-2031)

5.2.1 Global Antiemetic Drugs Revenue by Application (2020-2025)

5.2.2 Global Antiemetic Drugs Revenue by Application (2026-2031)

5.2.3 Global Antiemetic Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Antiemetic Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Company Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Company Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Johnson & Johnson Antiemetic Drugs Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer Antiemetic Drugs Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Company Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sanofi Antiemetic Drugs Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Abbott

6.5.1 Abbott Company Information

6.5.2 Abbott Description and Business Overview

6.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Abbott Antiemetic Drugs Product Portfolio

6.5.5 Abbott Recent Developments/Updates

6.6 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Company Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio

6.6.5 Bristol-Myers Squibb Recent Developments/Updates

6.7 Cipla

6.7.1 Cipla Company Information

6.7.2 Cipla Description and Business Overview

6.7.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Cipla Antiemetic Drugs Product Portfolio

6.7.5 Cipla Recent Developments/Updates

6.8 Eisai

6.8.1 Eisai Company Information

6.8.2 Eisai Description and Business Overview

6.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Eisai Antiemetic Drugs Product Portfolio

6.8.5 Eisai Recent Developments/Updates

6.9 Eli Lilly

6.9.1 Eli Lilly Company Information

6.9.2 Eli Lilly Description and Business Overview

6.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Eli Lilly Antiemetic Drugs Product Portfolio

6.9.5 Eli Lilly Recent Developments/Updates

6.10 Glenmark

6.10.1 Glenmark Company Information

6.10.2 Glenmark Description and Business Overview

6.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Glenmark Antiemetic Drugs Product Portfolio

6.10.5 Glenmark Recent Developments/Updates

6.11 Helsinn Healthcare

6.11.1 Helsinn Healthcare Company Information

6.11.2 Helsinn Healthcare Description and Business Overview

6.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio

6.11.5 Helsinn Healthcare Recent Developments/Updates

6.12 Heron Therapeutics

6.12.1 Heron Therapeutics Company Information

6.12.2 Heron Therapeutics Description and Business Overview

6.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Heron Therapeutics Antiemetic Drugs Product Portfolio

6.12.5 Heron Therapeutics Recent Developments/Updates

6.13 IPCA Laboratories

6.13.1 IPCA Laboratories Company Information

6.13.2 IPCA Laboratories Description and Business Overview

6.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 IPCA Laboratories Antiemetic Drugs Product Portfolio

6.13.5 IPCA Laboratories Recent Developments/Updates

6.14 Lupin

6.14.1 Lupin Company Information

6.14.2 Lupin Description and Business Overview

6.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Lupin Antiemetic Drugs Product Portfolio

6.14.5 Lupin Recent Developments/Updates

6.15 Merck

6.15.1 Merck Company Information

6.15.2 Merck Description and Business Overview

6.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Merck Antiemetic Drugs Product Portfolio

6.15.5 Merck Recent Developments/Updates

6.16 Novartis

6.16.1 Novartis Company Information

6.16.2 Novartis Description and Business Overview

6.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Novartis Antiemetic Drugs Product Portfolio

6.16.5 Novartis Recent Developments/Updates

6.17 RedHill

6.17.1 RedHill Company Information

6.17.2 RedHill Description and Business Overview

6.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.17.4 RedHill Antiemetic Drugs Product Portfolio

6.17.5 RedHill Recent Developments/Updates

6.18 Sun Pharmaceutical Industries

6.18.1 Sun Pharmaceutical Industries Company Information

6.18.2 Sun Pharmaceutical Industries Description and Business Overview

6.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio

6.18.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.19 Takeda Pharmaceutical

6.19.1 Takeda Pharmaceutical Company Information

6.19.2 Takeda Pharmaceutical Description and Business Overview

6.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio

6.19.5 Takeda Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antiemetic Drugs Industry Chain Analysis

7.2 Antiemetic Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antiemetic Drugs Production Mode & Process Analysis

7.4 Antiemetic Drugs Sales and Marketing

7.4.1 Antiemetic Drugs Sales Channels

7.4.2 Antiemetic Drugs Distributors

7.5 Antiemetic Drugs Customer Analysis

8 Antiemetic Drugs Market Dynamics

8.1 Antiemetic Drugs Industry Trends

8.2 Antiemetic Drugs Market Drivers

8.3 Antiemetic Drugs Market Challenges

8.4 Antiemetic Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sun Pharmaceutical Industries

Takeda Pharmaceutical

List of Tables

Table 1. Global Antiemetic Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Antiemetic Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Antiemetic Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Antiemetic Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Antiemetic Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Antiemetic Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Antiemetic Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Antiemetic Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Antiemetic Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antiemetic Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antiemetic Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Antiemetic Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antiemetic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiemetic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Antiemetic Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Antiemetic Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Antiemetic Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Antiemetic Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Antiemetic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Antiemetic Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Antiemetic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Antiemetic Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Antiemetic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Antiemetic Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Antiemetic Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Antiemetic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Antiemetic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Antiemetic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Antiemetic Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Antiemetic Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Antiemetic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Antiemetic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Antiemetic Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Antiemetic Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Antiemetic Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Antiemetic Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Antiemetic Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Antiemetic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Antiemetic Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Antiemetic Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Antiemetic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Antiemetic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Antiemetic Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Antiemetic Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Antiemetic Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Antiemetic Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Antiemetic Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Antiemetic Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Antiemetic Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Antiemetic Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Antiemetic Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Antiemetic Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Antiemetic Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Antiemetic Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Antiemetic Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Antiemetic Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Antiemetic Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Antiemetic Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Antiemetic Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Antiemetic Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Antiemetic Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Antiemetic Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Antiemetic Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Antiemetic Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Antiemetic Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Antiemetic Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Antiemetic Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. GlaxoSmithKline Company Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GlaxoSmithKline Antiemetic Drugs Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Johnson & Johnson Company Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Johnson & Johnson Antiemetic Drugs Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Pfizer Antiemetic Drugs Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Sanofi Company Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Sanofi Antiemetic Drugs Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Abbott Company Information

Table 91. Abbott Description and Business Overview

Table 92. Abbott Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Abbott Antiemetic Drugs Product

Table 94. Abbott Recent Developments/Updates

Table 95. Bristol-Myers Squibb Company Information

Table 96. Bristol-Myers Squibb Description and Business Overview

Table 97. Bristol-Myers Squibb Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Bristol-Myers Squibb Antiemetic Drugs Product

Table 99. Bristol-Myers Squibb Recent Developments/Updates

Table 100. Cipla Company Information

Table 101. Cipla Description and Business Overview

Table 102. Cipla Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Cipla Antiemetic Drugs Product

Table 104. Cipla Recent Developments/Updates

Table 105. Eisai Company Information

Table 106. Eisai Description and Business Overview

Table 107. Eisai Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Eisai Antiemetic Drugs Product

Table 109. Eisai Recent Developments/Updates

Table 110. Eli Lilly Company Information

Table 111. Eli Lilly Description and Business Overview

Table 112. Eli Lilly Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Eli Lilly Antiemetic Drugs Product

Table 114. Eli Lilly Recent Developments/Updates

Table 115. Glenmark Company Information

Table 116. Glenmark Description and Business Overview

Table 117. Glenmark Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Glenmark Antiemetic Drugs Product

Table 119. Glenmark Recent Developments/Updates

Table 120. Helsinn Healthcare Company Information

Table 121. Helsinn Healthcare Description and Business Overview

Table 122. Helsinn Healthcare Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Helsinn Healthcare Antiemetic Drugs Product

Table 124. Helsinn Healthcare Recent Developments/Updates

Table 125. Heron Therapeutics Company Information

Table 126. Heron Therapeutics Description and Business Overview

Table 127. Heron Therapeutics Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Heron Therapeutics Antiemetic Drugs Product

Table 129. Heron Therapeutics Recent Developments/Updates

Table 130. IPCA Laboratories Company Information

Table 131. IPCA Laboratories Description and Business Overview

Table 132. IPCA Laboratories Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. IPCA Laboratories Antiemetic Drugs Product

Table 134. IPCA Laboratories Recent Developments/Updates

Table 135. Lupin Company Information

Table 136. Lupin Description and Business Overview

Table 137. Lupin Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Lupin Antiemetic Drugs Product

Table 139. Lupin Recent Developments/Updates

Table 140. Merck Company Information

Table 141. Merck Description and Business Overview

Table 142. Merck Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Merck Antiemetic Drugs Product

Table 144. Merck Recent Developments/Updates

Table 145. Novartis Company Information

Table 146. Novartis Description and Business Overview

Table 147. Novartis Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Novartis Antiemetic Drugs Product

Table 149. Novartis Recent Developments/Updates

Table 150. RedHill Company Information

Table 151. RedHill Description and Business Overview

Table 152. RedHill Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. RedHill Antiemetic Drugs Product

Table 154. RedHill Recent Developments/Updates

Table 155. Sun Pharmaceutical Industries Company Information

Table 156. Sun Pharmaceutical Industries Description and Business Overview

Table 157. Sun Pharmaceutical Industries Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. Sun Pharmaceutical Industries Antiemetic Drugs Product

Table 159. Sun Pharmaceutical Industries Recent Developments/Updates

Table 160. Takeda Pharmaceutical Company Information

Table 161. Takeda Pharmaceutical Description and Business Overview

Table 162. Takeda Pharmaceutical Antiemetic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 163. Takeda Pharmaceutical Antiemetic Drugs Product

Table 164. Takeda Pharmaceutical Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Antiemetic Drugs Distributors List

Table 168. Antiemetic Drugs Customers List

Table 169. Antiemetic Drugs Market Trends

Table 170. Antiemetic Drugs Market Drivers

Table 171. Antiemetic Drugs Market Challenges

Table 172. Antiemetic Drugs Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

Table 176. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antiemetic Drugs

Figure 2. Global Antiemetic Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Antiemetic Drugs Market Share by Type: 2024 & 2031

Figure 4. Dopamine Antagonist Product Picture

Figure 5. 5-HT-3 Receptor Antagonist Product Picture

Figure 6. NK1 Receptor Antagonist Product Picture

Figure 7. Cannabinoid Receptor Antagonist Product Picture

Figure 8. Global Antiemetic Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Antiemetic Drugs Market Share by Application: 2024 & 2031

Figure 10. Chemotherapy

Figure 11. Gastroenteritis

Figure 12. Surgery

Figure 13. Global Antiemetic Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Antiemetic Drugs Market Size (2020-2031) & (US$ Million)

Figure 15. Global Antiemetic Drugs Sales (2020-2031) & (K Units)

Figure 16. Global Antiemetic Drugs Average Price (USD/Unit) & (2020-2031)

Figure 17. Antiemetic Drugs Report Years Considered

Figure 18. Antiemetic Drugs Sales Share by Manufacturers in 2024

Figure 19. Global Antiemetic Drugs Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Antiemetic Drugs Players: Market Share by Revenue in Antiemetic Drugs in 2024

Figure 21. Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Antiemetic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Antiemetic Drugs Sales Market Share by Country (2020-2031)

Figure 24. North America Antiemetic Drugs Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Antiemetic Drugs Sales Market Share by Country (2020-2031)

Figure 28. Europe Antiemetic Drugs Revenue Market Share by Country (2020-2031)

Figure 29. Germany Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Antiemetic Drugs Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Antiemetic Drugs Revenue Market Share by Region (2020-2031)

Figure 36. China Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Antiemetic Drugs Sales Market Share by Country (2020-2031)

Figure 47. Latin America Antiemetic Drugs Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Antiemetic Drugs Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Antiemetic Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Antiemetic Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Antiemetic Drugs by Type (2020-2031)

Figure 57. Global Revenue Market Share of Antiemetic Drugs by Type (2020-2031)

Figure 58. Global Antiemetic Drugs Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Antiemetic Drugs by Application (2020-2031)

Figure 60. Global Revenue Market Share of Antiemetic Drugs by Application (2020-2031)

Figure 61. Global Antiemetic Drugs Price (USD/Unit) by Application (2020-2031)

Figure 62. Antiemetic Drugs Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions